Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Glucocorticoids induce apoptosis in lymphocytes by causing the release of cytochrome c into the cytosol; however, the events in the signaling phase between translocation of the steroid-receptor complex to the nucleus and the release of cytochrome c have not been elucidated. Previously, we found that, in response to steroid treatment, WEHI7.2 mouse thymic lymphoma cells overexpressing catalase (CAT38) show delayed apoptosis (delayed cytochrome c release) compared to the parental cells, while Bcl-2 overexpressing cells (Hb12) are protected from steroid-induced apoptosis. In lymphocytes, glucocorticoid treatment decreases glucose uptake. Both glucose deprivation and the attendant ATP drop are known inducers of apoptosis. Therefore, we used 31P and 1H NMR spectroscopy to compare metabolic profiles of WEHI7.2, CAT38 and Hb12 cells in the presence and absence of dexamethasone to determine: (1) whether glucocorticoid effects on glucose metabolism contribute to the mechanism of steroid-induced apoptosis; and (2) whether catalase or Bcl-2 overexpression altered metabolism thereby providing a mechanism of steroid resistance. Loss of mitochondrial hexokinase activity was correlated to the induction of apoptosis in WEHI7.2 and CAT38 cells. CAT38 and Hb12 cells have an altered basal metabolism which includes increases in hexokinase activity, lactate production when subcultured into new medium, use of mitochondria for ATP production and potentially increased glutaminolysis. These data suggest that: (1) glucocorticoid effects on glucose metabolism may contribute to the mechanism of steroid-induced lymphocyte apoptosis; and (2) the altered metabolism seen in catalase and Bcl-2 overexpressing cells may contribute to both the steroid resistance and increased tumorigenicity of these variants.

Original languageEnglish (US)
Pages (from-to)57-72
Number of pages16
JournalBBA - Molecular Cell Research
Volume1693
Issue number1
DOIs
StatePublished - Jul 23 2004

Fingerprint

Catalase
Energy Metabolism
Dexamethasone
Apoptosis
Glucose
Steroids
Glucocorticoids
Cytochromes c
Hexokinase
Lymphocytes
Adenosine Triphosphate
Basal Metabolism
Metabolome
Steroid Receptors
Cytosol
Lactic Acid
Lymphoma
Mitochondria
Magnetic Resonance Spectroscopy

Keywords

  • ala
  • alanine
  • Apoptosis
  • asp
  • aspartate
  • carbonyl cyanide m-chlorophenylhydrazine
  • CAT38
  • CCCP
  • ethanol
  • EtOH
  • gln
  • glu
  • glutamate
  • glutamine
  • glycerol 3-phosphate
  • Gro-3-P
  • Hexokinase
  • Lymphocyte
  • NMR
  • Steroid
  • WEHI7.2 cells expressing 1.4-fold parental cell catalase

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Biophysics

Cite this

Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance. / Tome, Margaret E; Lutz, Norbert W.; Briehl, Margaret M.

In: BBA - Molecular Cell Research, Vol. 1693, No. 1, 23.07.2004, p. 57-72.

Research output: Contribution to journalArticle

@article{187eba0da4bd46d685d0edfb8a1c8eea,
title = "Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance",
abstract = "Glucocorticoids induce apoptosis in lymphocytes by causing the release of cytochrome c into the cytosol; however, the events in the signaling phase between translocation of the steroid-receptor complex to the nucleus and the release of cytochrome c have not been elucidated. Previously, we found that, in response to steroid treatment, WEHI7.2 mouse thymic lymphoma cells overexpressing catalase (CAT38) show delayed apoptosis (delayed cytochrome c release) compared to the parental cells, while Bcl-2 overexpressing cells (Hb12) are protected from steroid-induced apoptosis. In lymphocytes, glucocorticoid treatment decreases glucose uptake. Both glucose deprivation and the attendant ATP drop are known inducers of apoptosis. Therefore, we used 31P and 1H NMR spectroscopy to compare metabolic profiles of WEHI7.2, CAT38 and Hb12 cells in the presence and absence of dexamethasone to determine: (1) whether glucocorticoid effects on glucose metabolism contribute to the mechanism of steroid-induced apoptosis; and (2) whether catalase or Bcl-2 overexpression altered metabolism thereby providing a mechanism of steroid resistance. Loss of mitochondrial hexokinase activity was correlated to the induction of apoptosis in WEHI7.2 and CAT38 cells. CAT38 and Hb12 cells have an altered basal metabolism which includes increases in hexokinase activity, lactate production when subcultured into new medium, use of mitochondria for ATP production and potentially increased glutaminolysis. These data suggest that: (1) glucocorticoid effects on glucose metabolism may contribute to the mechanism of steroid-induced lymphocyte apoptosis; and (2) the altered metabolism seen in catalase and Bcl-2 overexpressing cells may contribute to both the steroid resistance and increased tumorigenicity of these variants.",
keywords = "ala, alanine, Apoptosis, asp, aspartate, carbonyl cyanide m-chlorophenylhydrazine, CAT38, CCCP, ethanol, EtOH, gln, glu, glutamate, glutamine, glycerol 3-phosphate, Gro-3-P, Hexokinase, Lymphocyte, NMR, Steroid, WEHI7.2 cells expressing 1.4-fold parental cell catalase",
author = "Tome, {Margaret E} and Lutz, {Norbert W.} and Briehl, {Margaret M}",
year = "2004",
month = "7",
day = "23",
doi = "10.1016/j.bbamcr.2004.05.004",
language = "English (US)",
volume = "1693",
pages = "57--72",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance

AU - Tome, Margaret E

AU - Lutz, Norbert W.

AU - Briehl, Margaret M

PY - 2004/7/23

Y1 - 2004/7/23

N2 - Glucocorticoids induce apoptosis in lymphocytes by causing the release of cytochrome c into the cytosol; however, the events in the signaling phase between translocation of the steroid-receptor complex to the nucleus and the release of cytochrome c have not been elucidated. Previously, we found that, in response to steroid treatment, WEHI7.2 mouse thymic lymphoma cells overexpressing catalase (CAT38) show delayed apoptosis (delayed cytochrome c release) compared to the parental cells, while Bcl-2 overexpressing cells (Hb12) are protected from steroid-induced apoptosis. In lymphocytes, glucocorticoid treatment decreases glucose uptake. Both glucose deprivation and the attendant ATP drop are known inducers of apoptosis. Therefore, we used 31P and 1H NMR spectroscopy to compare metabolic profiles of WEHI7.2, CAT38 and Hb12 cells in the presence and absence of dexamethasone to determine: (1) whether glucocorticoid effects on glucose metabolism contribute to the mechanism of steroid-induced apoptosis; and (2) whether catalase or Bcl-2 overexpression altered metabolism thereby providing a mechanism of steroid resistance. Loss of mitochondrial hexokinase activity was correlated to the induction of apoptosis in WEHI7.2 and CAT38 cells. CAT38 and Hb12 cells have an altered basal metabolism which includes increases in hexokinase activity, lactate production when subcultured into new medium, use of mitochondria for ATP production and potentially increased glutaminolysis. These data suggest that: (1) glucocorticoid effects on glucose metabolism may contribute to the mechanism of steroid-induced lymphocyte apoptosis; and (2) the altered metabolism seen in catalase and Bcl-2 overexpressing cells may contribute to both the steroid resistance and increased tumorigenicity of these variants.

AB - Glucocorticoids induce apoptosis in lymphocytes by causing the release of cytochrome c into the cytosol; however, the events in the signaling phase between translocation of the steroid-receptor complex to the nucleus and the release of cytochrome c have not been elucidated. Previously, we found that, in response to steroid treatment, WEHI7.2 mouse thymic lymphoma cells overexpressing catalase (CAT38) show delayed apoptosis (delayed cytochrome c release) compared to the parental cells, while Bcl-2 overexpressing cells (Hb12) are protected from steroid-induced apoptosis. In lymphocytes, glucocorticoid treatment decreases glucose uptake. Both glucose deprivation and the attendant ATP drop are known inducers of apoptosis. Therefore, we used 31P and 1H NMR spectroscopy to compare metabolic profiles of WEHI7.2, CAT38 and Hb12 cells in the presence and absence of dexamethasone to determine: (1) whether glucocorticoid effects on glucose metabolism contribute to the mechanism of steroid-induced apoptosis; and (2) whether catalase or Bcl-2 overexpression altered metabolism thereby providing a mechanism of steroid resistance. Loss of mitochondrial hexokinase activity was correlated to the induction of apoptosis in WEHI7.2 and CAT38 cells. CAT38 and Hb12 cells have an altered basal metabolism which includes increases in hexokinase activity, lactate production when subcultured into new medium, use of mitochondria for ATP production and potentially increased glutaminolysis. These data suggest that: (1) glucocorticoid effects on glucose metabolism may contribute to the mechanism of steroid-induced lymphocyte apoptosis; and (2) the altered metabolism seen in catalase and Bcl-2 overexpressing cells may contribute to both the steroid resistance and increased tumorigenicity of these variants.

KW - ala

KW - alanine

KW - Apoptosis

KW - asp

KW - aspartate

KW - carbonyl cyanide m-chlorophenylhydrazine

KW - CAT38

KW - CCCP

KW - ethanol

KW - EtOH

KW - gln

KW - glu

KW - glutamate

KW - glutamine

KW - glycerol 3-phosphate

KW - Gro-3-P

KW - Hexokinase

KW - Lymphocyte

KW - NMR

KW - Steroid

KW - WEHI7.2 cells expressing 1.4-fold parental cell catalase

UR - http://www.scopus.com/inward/record.url?scp=3242754314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242754314&partnerID=8YFLogxK

U2 - 10.1016/j.bbamcr.2004.05.004

DO - 10.1016/j.bbamcr.2004.05.004

M3 - Article

C2 - 15276325

AN - SCOPUS:3242754314

VL - 1693

SP - 57

EP - 72

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 1

ER -